It seems the world is getting smaller, as populations get larger and more citizens rise to the level of the middle class. These factors mean that there are more patients that can afford quality healthcare than ever before and that the pharmaceutical industry can no longer just concentrate on the U.S., Europe and Japan.
Each of these new global markets — from China to India to Brazil — offers pharma companies its own set of challenges, but its own set of rewards as well. For instance, the Chinese government is pulling down regulatory hurdles to make development of innovative drugs in China a reality. Meanwhile, drug manufacturers in India are working hard to become global players, but have been thwarted by continued quality control issues.
In this latest Spotlight edition, BioPharma Dive is going on a world exploration to highlight the wonders that these younger markets offer and the hurdles that lay ahead.
Lisa LaMotta
Senior Editor, BioPharma Dive
E-mail
News and Trends
|
Feature Story
As healthcare becomes a global economy, pharma companies face a slew of challenges as they try to commercialize in multiple markets across the globe.
|
|
Feature Story
Despite a major regulatory shift, China's ascendency as the next global hub of drug R&D may still be a ways off.
|
|
Feature Story
A poor patient population, a tricky tax code and turmoil within the government have created obstacles for pharma companies entering the Brazilian market.
|
|
Feature Story
Indian drug manufacturers are looking to be bigger players in the global market, but quality control continues to be a challenge.
|
|
Feature Story
Nineteen cities have bid to become the regulatory agency's new home, now that Brexit has forced the European Medicines Agency to relocate from London.
|
|
Feature Story
CFDA announced draft guidelines that would allow Phase I trials in China to encourage simultaneous development alongside global trials.
|
Featured Resources
|
A guide to using translation best practices to launch cost-effective clinical trials in international markets. Find out more →
|
|
Creating clinical labels in multiple languages doesn’t have to be a complex process. Learn how to simplify the multilingual clinical labeling process. Download now →
|
|
With the Pharmaceutical industry operating on a global scale, it must contend with geographic shifts in local and regional markets in order to stay competitive. Learn more →
|
What We're Reading
The New York Times
|
Strategy+Business
|
Nikkei Asian Review
|
Politico
|
|
